Director, Global Value and Health Economics, Outcomes Research

🕒 il y a 3 jours

🏄 California, Pennsylvania – Distant

🏄 California – Remote 🔔 Pennsylvania – Remote

💵 $212 000 - $318 000 / an

⏰ Temps Plein

🔴 Expert

👔 Directeur

🦅 Parrain de Visa H1B

Cette entreprise a parrainé des visas H1B par le passé.

👻 Score fantôme 0%

Ce que ça veut dire : la probabilité que personne ne recrute vraiment pour cette offre.Comment le lire : 60 % ou plus, on pense que c'est une offre fantôme. Un score plus bas est moins inquiétant.Comment on la calcule : ancienneté, republications, postes ouverts vs taille de l'équipe, rapidité de clôture, et si le salaire est indiqué.À noter : une estimation à partir de données publiques, pas un jugement sur l'entreprise. De vraies offres peuvent avoir un score élevé, alors prenez-le comme un indice, pas comme un fait.

Postuler Maintenant

Trouver des Emplois à Distance Similaires

Jazz Pharmaceuticals

Site WebLinkedInTous les Emplois

1001 - 5000 employés

Fondée en 2003

🏥 Santé

🏭 Fabrication

🧬 Biotechnologie

Healthcare • Manufacturing • Biotechnology

Jazz Pharmaceuticals est une entreprise biopharmaceutique dédiée au développement de médicaments innovants répondant à des besoins médicaux sérieux non satisfaits. Avec un fort engagement envers la recherche et le développement, Jazz se concentre sur la création de thérapies transformatrices, mettant en avant l'importance de la collaboration, de la diversité et de l'engagement des employés dans ses opérations. L'entreprise est fière de transformer la vie des patients grâce à ses offres de produits significatives et une culture qui favorise l'enthousiasme et la flexibilité.

Description

• Define and execute global and US payer evidence strategies in Oncology • Lead global HEOR activities and strategies in gastroesophageal adenocarcinoma and support a major Oncology asset’s clinical pipeline • Embed payer, HTA, and reimbursement requirements into Phase 2 and Phase 3 clinical development programs • Serve as US HEOR lead for commercial, Medicare Part B/D, and Medicaid access • Execute and author AMCP dossiers, US commercial/Medicare budget impact models, and state Medicaid submission packages • Enable US Payer Field Teams with interactive economic models, slide decks, and digital tools • Monitor US health policy and prepare evidence roadmaps for IRA, CMS Drug Price Negotiation, Part D redesign, ICER reviews, and NCCN Evidence Blocks • Advise on innovative payment models and value-based contracts • Design and execute health economic models, including CEA, CUA, and BIM, across the product lifecycle • Direct global core economic model architecture and validation • Lead global value dossiers, systematic literature reviews, global evidence libraries, ITCs, NMAs, and economic model adaptations • Collaborate on real-world evidence, natural history, burden-of-illness, treatment-pattern, and comparative-effectiveness studies • Lead HEOR launch readiness, lifecycle management, label expansion, value defense, and post-launch evidence programs • Govern HEOR commitments in Integrated Evidence Generation Plans • Partner with Market Access, Brand Teams, Medical Affairs, Clinical Development, Regulatory, Commercial, and EU/INT HEOR teams • Lead publications and presentations at scientific and health economic congresses • Mentor junior scientists, cross-functional colleagues, and HEOR fellows • Ensure compliance with legal, regulatory, and corporate standards

🎯 Exigences

• Master’s degree (MSc, MS, MPH, PhD) in Health Economics, Outcomes Research, Pharmacoeconomics, or a closely related quantitative field • 7–10 years of experience in HEOR, Global Value, or Health Economics within the biopharmaceutical industry or a top-tier HEOR consulting firm • Experience with oncology assets preferred • Track record leading HEOR strategy and executing evidence deliverables for marketed, inline pharmaceutical products, including lifecycle management, label expansions, and value defense • Deep understanding of US payers and population health decision makers, including Oncology Pathways • Experience managing regional trade-offs on evidence needs during Phase 2/3 protocol development • Launch lead for at least 2 assets as US HEOR lead or country-level HTA lead • Proven track record as US HEOR lead or driving US pre-launch HEOR deliverables, including AMCP PIE dossiers, US budget impact models, and payer field enablement • Experience conducting post-marketing RWE, patient registry studies, and economic evaluations in rare diseases, specialized medicine, or complex chronic conditions • Experience collaborating with regional HEOR teams, such as EU/INT, on global HTA reassessments, renewals, or pricing renegotiations • Strong peer-reviewed publication record in health economics and outcomes research • Deep knowledge of US managed care archetypes and international HTA systems • Advanced expertise in health economic modeling, including Markov, partitioned survival, microsimulation, and discrete event simulation • Track record partnering with US Payer Field Teams to develop interactive economic models and value presentation tools • Practical rare disease/orphan drug access expertise • Experience with launch readiness, lifecycle management, clinical trial design, policy, value assessments, matrix leadership, mentorship, project, budget, and vendor management • Familiarity with FDAMA Section 114, 21st Century Cures Act, EU JCA, NICE, G-BA, and CADTH

🏖️ Avantages

• Discretionary annual cash bonus or incentive compensation • Discretionary equity grants through the Long Term Equity Incentive Plan • Medical insurance • Dental insurance • Vision insurance • 401k retirement savings plan • Flexible paid vacation

📊 Vérifiez votre score de CV pour ce poste

Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

Télécharger le CV